Loading
Yanuki
KEYWORD TOPIC
IMUNON Withdraws SEC Registration for Planned Public Offering | IMUNON Withdraws SEC Registration for Planned Public Offering

News / Finance

IMUNON Withdraws SEC Registration for Planned Public Offering

IMUNON Inc. (NASDAQ: IMNN), a clinical-stage biotechnology company, has withdrawn its S-1 registration statement filed with the SEC, effectively canceling its planned public offering. The decision was made as the company no longer intends t...

Phase 3 Biotech IMUNON Halts Public Offering Plans: What This Means for DNA Immunotherapy Pipeline
IMUNON Withdraws SEC Registration for Planned Public Offering Image via Stock Titan
TOPIC imnn stock